R R

What Is Plaquenil?

Plaquenil is a prescription medication containing hydroxychloroquine sulfate, an antimalarial and disease-modifying antirheumatic drug. It is approved to treat rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults. It is also used to treat or prevent certain forms of malaria when the organisms are susceptible. Plaquenil affects immune and inflammatory activity, helping control symptoms of selected autoimmune diseases. Long-term treatment requires monitoring because hydroxychloroquine can damage the retina and cause potentially irreversible vision changes.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Plaquenil?

Plaquenil is a prescription medication containing hydroxychloroquine sulfate, an antimalarial and disease-modifying antirheumatic drug. It is approved to treat rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults. It is also used to treat or prevent certain forms of malaria when the organisms are susceptible. Plaquenil affects immune and inflammatory activity, helping control symptoms of selected autoimmune diseases. Long-term treatment requires monitoring because hydroxychloroquine can damage the retina and cause potentially irreversible vision changes.

read more about plaquenil ...

Copy this HTML:

Copy HTML Copied!

How Does Plaquenil Work?

Hydroxychloroquine accumulates within cellular compartments and influences processes involved in immune signaling, including antigen processing and certain inflammatory pathways. These effects help reduce immune activity associated with rheumatoid arthritis and lupus. Its complete mechanism in autoimmune disease is not fully established. Against susceptible malaria parasites, hydroxychloroquine interferes with processes involved in parasite survival within red blood cells. The medicine does not act immediately on chronic autoimmune symptoms, and improvement can develop gradually over several weeks or months. Hydroxychloroquine is not effective against all malaria strains.

What Conditions Does Plaquenil Treat?

Plaquenil is approved for rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults. It is also approved for treatment of uncomplicated malaria caused by specified Plasmodium species and prevention of malaria in areas where chloroquine resistance has not been reported. Plaquenil is not recommended for complicated malaria or infections caused by chloroquine-resistant parasites. It also does not eradicate dormant liver forms of certain malaria parasites. A healthcare professional considers the diagnosis, body weight, kidney health, existing eye conditions, and medication interactions before prescribing treatment.

How Should Plaquenil Be Taken?

Plaquenil is taken orally with food or milk. For rheumatoid arthritis, adults commonly begin treatment at 400 mg to 600 mg daily, followed by lower maintenance doses according to clinical response. Lupus regimens commonly involve 200 mg to 400 mg daily. Malaria treatment and prevention use separate weight-based schedules. The tablets should not be crushed or divided. Dosing is individualized to limit toxicity, including retinal damage. A baseline eye examination is recommended within the first year of treatment, followed by retinal monitoring based on individual risk factors and duration of use.

What Are the Side Effects and Warnings of Plaquenil?

Common side effects include nausea, diarrhea, abdominal pain, headache, and skin reactions. A serious risk is retinal toxicity, which can cause irreversible vision loss and may progress even after treatment stops. Risk increases with higher daily doses, longer treatment duration, kidney impairment, certain concurrent medications, and existing retinal disease. Plaquenil can also cause heart rhythm abnormalities, cardiomyopathy, low blood sugar, severe skin reactions, and neuropsychiatric symptoms. Patients should report blurred vision, difficulty reading, changes in visual fields, palpitations, or severe mood changes. Regular ophthalmic screening is recommended during long-term treatment.

Common Questions About Plaquenil

Is Plaquenil the same as hydroxychloroquine?

Yes. Plaquenil is a brand name for hydroxychloroquine sulfate, a medication used for certain autoimmune conditions and susceptible malaria infections.

Can Plaquenil treat lupus?

Yes. Plaquenil is approved to treat systemic lupus erythematosus and chronic discoid lupus erythematosus in adults.

Why are eye examinations necessary during Plaquenil treatment?

Hydroxychloroquine can cause retinal damage that may be irreversible. Baseline and follow-up eye examinations help detect toxicity before substantial vision loss develops.

Can contact lenses prevent Plaquenil-related vision problems?

No. Contact lenses correct refractive errors but cannot prevent or treat hydroxychloroquine-related retinal toxicity. Retinal screening and medical supervision remain necessary.

References

DailyMed - PLAQUENIL (hydroxychloroquine sulfate) tablet. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34496b43-05a2-45fb-a769-52b12e099341. Date Accessed November 2, 2026.

Hydroxychloroquine. LiverTox. https://www.ncbi.nlm.nih.gov/books/NBK548738/. Date Accessed November 2, 2026.

Hydroxychloroquine. MedlinePlus. https://medlineplus.gov/druginfo/meds/a601240.html. Date Accessed November 2, 2026.

Hydroxychloroquine. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxychloroquine. Date Accessed November 2, 2026.

Special AAO Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2025 Revision). Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/41232611/. Date Accessed November 2, 2026.